A new study published in the Journal of American Medical Association showed that nirsevimab offers protection against a ...

Vermont has the second lowest state fatality rate in the US (146.3 per 100K; Hawaii 112.7/100K). Mississippi (462.8/100K) and ...

AstraZeneca and Sanofi are leading the charge here with nirsevimab, a long-acting antibody designed to provide passive protection to infants through their first RSV season with a single dose.

At a meeting to present its vaccines pipeline to investors today, the French pharma is highlighting the potential of Beyfortus (nirsevimab) for the protection of infants in their first RSV season ...

“Nirsevimab, very exciting, also known as Beyfortus, is a monoclonal antibody. It is recommended for infants under the age of 8 months entering their first RSV season,” Capusan explained. While supply ...

At close: March 18 at 5:29:59 PM GMT+1 Loading Chart for SOBI.ST ...

The Maine CDC is excited to announce that we are modernizing our Tuberculosis (TB) reporting system. Currently, inactive TB (also known as Latent TB Infection or LTBI) cases and suspect and confirmed ...

Two new studies on respiratory syncytial virus (RSV) find that older adults, those residing in rural areas, those with certain conditions, and nursing home residents had higher rates of ...

Health care providers including hospitals can order publicly funded vaccines for their clients via Toronto Public Health (TPH). The process differs by product. Please read the eligibility criteria and ...

September 5, 2018 - Advisory (PDF) Prevention of Perinatal HIV in Maine - ...